| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |